• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

OPDP

BeOne Medicines Brukinsa TV ad
Marketing

FDA chides BeOne, ImmunityBio in separate untitled letters

The steady stream of FDA untitled letters that began in September is showing no signs of letting up in the new year.
Andrea Park Jan 15, 2026 11:50am
AstraZeneca Farxiga ad

FDA takes issue with AstraZeneca TV ad for Farxiga

Nov 18, 2025 10:50am
Novartis Fabhalta ad major statement

Novartis earns FDA ire for 'misleading' Fabhalta ad imagery

Sep 30, 2025 11:12am
Sprout Pharmaceuticals Addyi

Sprout hit with FDA warning letter over CEO’s Instagram post

Jun 12, 2025 12:00pm
Senator Dick Durbin

Senator probes FDA drug ad regulation after OPDP cuts

May 30, 2025 10:10am
dominoes stop stall halt end red

FDA ad watchers take umbrage at Xeris' 'misleading claims'

Jun 14, 2023 9:15am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings